The maker of a pregnancy medication takes action against the federal agency for not stopping pharmacies from making and selling cheaper versions of the drug.
The Scientist
Most Recent
The placebo effect in clinical trials of the mental disorder has increased over the past decade.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
Industry experts discuss the agency’s plans to make the drug approval process more transparent.
More than half of pharmaceutical companies on Twitter use more than one handle.
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
The FDA approves drugs faster and earlier than regulatory agencies in other countries.
The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.
The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.
A human enzyme grown in carrot cells will treat patients with Gaucher disease.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
